Relationship between decreased function and O2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels

Research in Experimental Medicine

Volumn 198, Issue 3, 1998, Pages 109-121

  Yan, Lin ^a   Gong, Gary X ^a   Tse, James ^a   Scholz, Peter M ^a   Weiss, Harvey R ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Calcium channels; Cyclic guanosine monophosphate; Myocyte contraction; Myocyte oxygen consumption; Nitric oxide

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL; CALCIUM ION; CYCLIC GMP; FORSKOLIN; NIFEDIPINE; NITROPRUSSIDE SODIUM; OXYGEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE OXYGEN CONSUMPTION; NONHUMAN; OXYGEN ELECTRODE; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELLS, CULTURED; CYCLIC GMP; FORSKOLIN; HEART; MUSCLE CONTRACTION; MYOCARDIUM; NIFEDIPINE; NITROPRUSSIDE; OXYGEN CONSUMPTION; RABBITS; RADIOIMMUNOASSAY;

EID: 0031752363     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004330050095     Document Type: Article

References (30)

1. Bkaily G, Sperelakis N (1985) Injection of guanosine-3′,5′-cyclic monophosphate into heart cells blocks calcium slow channels. Am J Physiol 248:H745-H749
2. Cornell TL, Arnold H, Boerth NJ, Lincoln TM (1994) Inhibition of smooth muscle growth hy nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267:C1405-C1413
3. Droogmans G, Nilius B (1989) Kinetic properties of the cardiac T-type calcium channel in the guinea-pig. J Physiol (Lond) 419:627-650
4. Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RI. (1995) Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther 272:945-952
5. Fischmeister R, Hartzell HC (1987) Cyclic guanosine-3′,5′-monophosphate regulates the calcium current in single cells from frog ventricle. J Physiol (Lond) 387:453-472
6. Gong GX, Weiss HR, Tse J, Scholz PM (1997) Cyclic GMP decreases cardiac myocyte oxygen consumption to a greater extent under conditions of increased metabolism. J Cardiovasc Pharmacol 30:537-543
7. 2+ current in single heart cells. Nature 323:273-275
8. Hove-Madsen L, Mery PF, Jurevicius J, Skeberdis AV, Fischmeister R (1996) Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol 91 [Suppl 2]: 1-8
9. Kristein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95:794-802
10. Kumar R, Namiki T, Joyner RW (1997) Effects of cGMP on L-type calcium current of adult and newborn rabbit ventricular cells. Cardiovasc Res 33:573-582
11. 2 consumption and positive inotropy caused by cyclic GMP reduction are not altered by L-type calcium channel blockade. Pharmacol 56:37-45
12. Lohmann SM., Fischmeister R, Walter U (1991) Signal transduction by cGMP in heart. Basic Res Cardiol 86:503-514
13. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci 88:1197-1201
14. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268:26286-26295
15. Murad F (1994) The nitric oxide-cGMP signal transduction system for intracellular and intracellular communication. Rec Prog Hormone Res 49:239-248
16. Nawrath H (1977) Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart? Nature 267:72-74
17. Rose H, Schnitzler N, Kammermeier H (1987) Electrically stimulated cardiomyocytes: evaluation of shortening, oxygen consumption and tracer uptake. Biomed Biochim Acta 9:622-627
18. Schmidt HHHW, Lohmann SM, Walter U (1993) The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178:153-175
19. 2+ in intact cardiac myocytes. Circ Res 74: 970-978
20. Sperelakis N (1994) Regulation of calcium slow channels of heart by cyclic nucleotides and effects of ischemia. Adv Pharmacol 31:1-24
21. ++ channels of myocardial cells. Mol Cell Biochem 64:85-98
22. Sperelakis N, Tohse N, Ohya Y, Masuda H (1994) Cyclic GMP regulation of calcium slow channels in cardiac muscle and vascular smooth muscle cells. Adv Pharmacol 26:217-252
23. 2 consumption is altered in renal hypertension. Am J Physiol 273:H1949-H1955
24. 2+ current in rat ventricular myocytes. Circ Res 77:803-812
25. 2+ channel activity by human natriuretic peptide in rabbit heart cells. Br J Pharmacol 114:1076-1082
26. Trautwein W, Taniguchi J, Noma A (1982) The effect of intracellular cyclic nucleotides and calcium on the action potential and acetylcholine response of isolated cardiac cells. Pflugers Arch 392:307-314
27. Wahler GM, Dollinger SJ (1995) Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol 268:C45-C54
28. Weiss HR, Rodriguez E, Tse J, Scholz PM (1994) Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin Exp Physiol Pharmacol 21:607-614
29. Wittenberg BA, Robinson TF (1981) Oxygen requirements, morphology, cell coat and membrane permeability of calcium-tolerant myocytes from hearts of adult rats. Cell Tissue Res 216:231-251
30. Yan L, Gong GX, Tse J, Scholz PM, Weiss HR (1998) Reduced function and metabolism caused by cGMP are altered by L-type calcium channels only at high adenylate cyclase activity. FASEB J 12:A73 (abstract)